For moderate-to-severe glaucoma, trabeculectomy remains the “gold standard” intraocular
pressure (IOP)-lowering treatment; nonetheless, this method requires extensive post …

Purpose: The purpose of this study was to assess the safety and efficacy of the PSM for the
treatment of open angle glaucoma with 0.2 mg/mL mitomycin C, either alone or in …

Background: The purpose of this study is to compare the morphology of six-month follow-up
blebs created by a subconjunctival glaucoma surgical device (XEN45) to those created by a …

Transient hypotony is the most common early complication after Preserflo MicroShunt (PMS)
implantation. High myopia is a risk factor for the development of postoperative hypotony …

Purpose Postoperative hypotony following PRESERFLO MicroShunt (PMS) implantation is a
frequent cause of complications such as choroidal detachment and hypotony maculopathy …

Glaucoma is a group of eye conditions that damage the optic nerve, the health of which is
vital for vision. The key risk factor for the development and progression of this disease is …

Many pharmaceutical and medical device start-up companies share similar goals. Each
experience is different and offers important lessons for companies seeking Food and Drug …

Purpose To investigate the possible risk factors for treatment failure in patients who had
undergone Preserflo Microshunt (PMS) implantation, using anterior-segment optical …

Purpose Patients with intraocular silicone oil (SO) display higher odds of surgical failure
after Ahmed glaucoma valve (AGV) implantation compared to patients without SO. However …

This study aims to investigate the pressure characteristics of the PRESERFLO MicroShunt, a
microinvasive glaucoma device, using an in vitro setup. Additionally, the study explores the …